Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anaptysbio Inc

18.51
-0.7800-4.04%
Post-market: 18.50-0.0100-0.05%19:54 EDT
Volume:853.32K
Turnover:15.87M
Market Cap:567.64M
PE:-3.62
High:19.36
Open:18.67
Low:18.06
Close:19.29
Loading ...

AnaptysBio Inc - Year-End 2024 Cash About $415 Mln

THOMSON REUTERS
·
11 Dec 2024

AnaptysBio Inc - Anb032 Ad Trial and All Further Investment Will Be Discontinued

THOMSON REUTERS
·
11 Dec 2024

AnaptysBio Inc - Anb032 Well Tolerated With No Safety Signals Observed

THOMSON REUTERS
·
11 Dec 2024

Anaptys Announces Phase 2B Trial of Anb032, a Btla Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis

THOMSON REUTERS
·
11 Dec 2024

AnaptysBio Inc: Anticipate Top-Line Phase 2B Data in Rheumatoid Arthritis in February 2025

THOMSON REUTERS
·
11 Dec 2024

Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis

GlobeNewswire
·
11 Dec 2024

AnaptysBio (ANAB) was downgraded to a Hold Rating at BTIG

TIPRANKS
·
10 Dec 2024

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Revvity (RVTY) and McKesson (MCK)

TIPRANKS
·
06 Dec 2024

AnaptysBio Cut to Neutral From Buy by BTIG

Dow Jones
·
02 Dec 2024

AnaptysBio Shares Down 6.4% After Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
02 Dec 2024

BTIG Downgrades AnaptysBio to Neutral From Buy

MT Newswires Live
·
02 Dec 2024

AnaptysBio Shares Down 3.85% Premarket After Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
02 Dec 2024

AnaptysBio Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
02 Dec 2024

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

Zacks
·
25 Nov 2024

Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher

Simply Wall St.
·
16 Nov 2024

TD Cowen Reaffirms Their Buy Rating on AnaptysBio (ANAB)

TIPRANKS
·
15 Nov 2024

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL), Molina Healthcare (MOH) and AnaptysBio (ANAB)

TIPRANKS
·
11 Nov 2024

AnaptysBio (ANAB) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
09 Nov 2024

Down -32.84% in 4 Weeks, Here's Why You Should You Buy the Dip in AnaptysBio (ANAB)

Zacks
·
08 Nov 2024

Analysts Are Bullish on Top Healthcare Stocks: AnaptysBio (ANAB), Outset Medical (OM)

TIPRANKS
·
07 Nov 2024